5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
-
5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
structure -
-
CAS No:
403811-55-2
-
Formula:
C12H11NOS2
-
Chemical Name:
5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
-
Synonyms:
4-Thiazolidinone,5-[(4-ethylphenyl)methylene]-2-thioxo-;5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone;10058F4
- Categories:
-
CAS No:
Description
10058-F4 is a c-Myc inhibitor that prevents c-Myc-Max dimerization and transactivation of c-Myc target gene expression.
10058-F4 is a member of the class of thiazolidinones that is 2-sulfanylidene-1,3-thiazolidin-4-one which is substituted at position 5 by a (4-ethylphenyl)methylidene group. It is a cell permeable inhibitor of c-Myc-Max dimerization and exhibits antitumour effects in vivo. It downregulates c-Myc expression and upregulates CDK inhibitors, p21 and p27 resulting in the inhibition of proliferation, induction of apoptosis and cell cycle arrest in G0/G1 phase. It has a role as an apoptosis inducer and an antineoplastic agent. It is a thiazolidinone and an olefinic compound.
Characteristics
86.5
3.6
yellow
1.3±0.1 g/cm3
387.1°C at 760 mmHg
187.9±30.7 °C
1.664
soluble in DMSO(>10mg/mL). soluble in water at concentrations less than 2mg/ml
2-8°C
Safety Information
IRRITANT
NONH for all modes of transport
3
36-43
26-36/37
Xi
P280-P305 + P351 + P338
H317-H319
|Warning|H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]|P261, P264, P272, P280, P302+P352, P305+P351+P338, P321, P333+P313, P337+P313, P363, and P501|Aggregated GHS information provided by 39 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Computed Properties
Molecular Weight:249.4
XLogP3:3.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:2
Exact Mass:249.02820632
Monoisotopic Mass:249.02820632
Topological Polar Surface Area:86.5
Heavy Atom Count:16
Complexity:330
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Latest News on 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4
5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
SDSRequest for Quotation